Human MicroRNA Oncogenes and Tumor Suppressors Show Significantly Different Biological Patterns: From Functions to Targets

Dong Wang, Chengxiang Qiu, Haijun Zhang, Juan Wang, Qinghua Cui, Yuxin YinPLoS 2010 · DOI

Abstract

MicroRNAs (miRNAs) are small noncoding RNAs which play essential roles in many important biological processes. Therefore, their dysfunction is associated with a variety of human diseases, including cancer. Increasing evidence shows that miRNAs can act as oncogenes or tumor suppressors, and although there is great interest in research into these cancer-associated miRNAs, little is known about them. In this study, we performed a comprehensive analysis of putative human miRNA oncogenes and tumor suppressors. We found that miRNA oncogenes and tumor suppressors clearly show different patterns in function, evolutionary rate, expression, chromosome distribution, molecule size, free energy, transcription factors, and targets. For example, miRNA oncogenes are located mainly in the amplified regions in human cancers, whereas miRNA tumor suppressors are located mainly in the deleted regions. miRNA oncogenes tend to cleave target mRNAs more frequently than miRNA tumor suppressors. These results indicate that these two types of cancer-associated miRNAs play different roles in cancer formation and development. Moreover, the patterns identified here can discriminate novel miRNA oncogenes and tumor suppressors with a high degree of accuracy. This study represents the first large-scale bioinformatic analysis of human miRNA oncogenes and tumor suppressors. Our findings provide help for not only understanding of miRNAs in cancer but also for the specific identification of novel miRNAs as miRNA oncogenes and tumor suppressors. In addition, the data presented in this study will be valuable for the study of both miRNAs and cancer.

Introduction

MicroRNAs (miRNAs) function as critical post-transcriptional regulators, often described as the "dimmer switches" of the human genome. By binding to target mRNAs, they can either inhibit translation or trigger mRNA degradation. In the context of oncology, miRNAs are categorized based on their influence on tumor progression: oncogenic miRNAs (p-oncomirs) promote tumor growth, while tumor-suppressive miRNAs (p-mirsupps) inhibit it.

While numerous studies have investigated individual miRNAs, a systematic, large-scale characterization of the fundamental biological differences between these two groups was previously lacking. This research addresses whether oncogenic and tumor-suppressive miRNAs possess distinct evolutionary, structural, and functional signatures that can be used to identify novel cancer-associated molecules.

Methodology and Data Integration

The researchers conducted a multi-dimensional bioinformatic audit of human miRNAs. The study began with a rigorous data culling process, manually reviewing approximately 5,000 publications to establish a high-confidence training set of 84 putative miRNA oncogenes and tumor suppressors.

The comparative analysis integrated data from several major biological repositories:

  • Evolutionary Conservation: Analyzed using miRBase and dbSNP to assess evolutionary pressure across five species groups.
  • Genomic Distribution: Evaluated chromosomal locations relative to fragile sites, deleted regions (DR), and amplified regions (AR) identified in landmark cancer genomics studies.
  • Expression Profiles: Utilized a dataset covering 40 normal human tissues to compare baseline expression levels.
  • Regulatory Networks: Transcription factor data was sourced from TransmiR, and experimentally validated target interactions were analyzed via TarBase (v5).

Finally, a machine-learning model was developed to test whether these identified biological patterns could accurately classify novel miRNAs.

Distinct Biological Signatures

The study revealed several striking differences between miRNA oncogenes and tumor suppressors:

Evolutionary Conservation

Tumor-suppressive miRNAs appear to be significantly older and more conserved than their oncogenic counterparts. Nearly 62% of suppressors belong to the most ancient conservation group (G1), whereas only 11.5% of oncogenes fall into this category. This suggests that tumor suppressors are fundamental "guardians of the genome" that have been preserved throughout evolution.

Genomic Localization and Copy Number

The genomic "real estate" occupied by these molecules aligns with their roles in cancer. miRNA oncogenes are predominantly located in regions frequently amplified in cancer (AR), facilitating a "gain of function." Conversely, tumor suppressors are typically found in regions prone to deletion (DR), leading to a "loss of function." Furthermore, tumor suppressors show a higher incidence of identical duplicates (28.6%), potentially acting as a redundant backup system for these critical regulatory functions.

Mechanisms of Target Regulation

A significant finding was the difference in how these miRNAs interact with their targets. miRNA tumor suppressors are more likely to employ mRNA cleavage (53.3% of actions) compared to oncogenes. This preference for cleavage suggests a more permanent method of inactivating target oncogenes. Additionally, a "cross-fire" pattern was statistically confirmed: miRNA oncogenes preferentially target protein-coding tumor suppressors, while miRNA tumor suppressors target protein-coding oncogenes.

Quantitative Results and Predictive Accuracy

The analysis showed that 96.8% of tumor-associated miRNAs are highly conserved, a stark contrast to the 21.3% conservation rate observed in the general miRNA population. In terms of baseline activity, tumor suppressors maintain significantly higher expression levels across normal tissues compared to oncogenes ($P = 8.01 \times 10^{-11}$).

The most significant practical outcome of this study is the predictive model. By leveraging these distinct biological features, the researchers achieved an 85.7% accuracy in discriminating between novel oncomirs and tumor suppressors.

Discussion and Future Directions

While this study provides a robust framework for understanding cancer-associated miRNAs, certain complexities remain. Some miRNAs exhibit "chameleon" behavior, acting as oncogenes in one tissue type and tumor suppressors in another. Future iterations of this model will need to incorporate tissue-specific contexts to account for this variability.

Additionally, while the study identifies a preference for mRNA cleavage among tumor suppressors, the underlying biochemical or structural reasons for this preference require further experimental investigation. As the volume of validated miRNA data grows, the patterns identified here will serve as a foundation for the more precise identification and therapeutic targeting of miRNAs in cancer.

Summary updated

Abstract

MicroRNAs (miRNAs) are small noncoding RNAs which play essential roles in many important biological processes. Therefore, their dysfunction is associated with a variety of human diseases, including cancer. Increasing evidence shows that miRNAs can act as oncogenes or tumor suppressors, and although there is great interest in research into these cancer-associated miRNAs, little is known about them. In this study, we performed a comprehensive analysis of putative human miRNA oncogenes and tumor suppressors. We found that miRNA oncogenes and tumor suppressors clearly show different patterns in function, evolutionary rate, expression, chromosome distribution, molecule size, free energy, transcription factors, and targets. For example, miRNA oncogenes are located mainly in the amplified regions in human cancers, whereas miRNA tumor suppressors are located mainly in the deleted regions. miRNA oncogenes tend to cleave target mRNAs more frequently than miRNA tumor suppressors. These results indicate that these two types of cancer-associated miRNAs play different roles in cancer formation and development. Moreover, the patterns identified here can discriminate novel miRNA oncogenes and tumor suppressors with a high degree of accuracy. This study represents the first large-scale bioinformatic analysis of human miRNA oncogenes and tumor suppressors. Our findings provide help for not only understanding of miRNAs in cancer but also for the specific identification of novel miRNAs as miRNA oncogenes and tumor suppressors. In addition, the data presented in this study will be valuable for the study of both miRNAs and cancer.
BibTeX
@inproceedings{wang2010human,
  author = {Dong Wang and Chengxiang Qiu and Haijun Zhang and Juan Wang and Qinghua Cui and Yuxin Yin},
  title = {{Human MicroRNA Oncogenes and Tumor Suppressors Show Significantly Different Biological Patterns: From Functions to Targets}},
  booktitle = {PLoS},
  year = {2010},
  doi = {10.1371/journal.pone.0013067},
}
Figure